Role of Metabolites in Nicotine Dependence (1) - 1
NCT00000284 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2017-01-12
Summary
The purpose of this study is to determine the effects of cotinine with or without a transdermal nicotine replacement on tobacco withdrawal symptoms.
Conditions
- Tobacco Use Disorder
Interventions
- DRUG
-
Cotinine fumarate
Sponsors & Collaborators
- collaborator OTHER
-
National Institute on Drug Abuse (NIDA)
lead NIH
Principal Investigators
-
Dorothy Hatsukami, Ph.D. · University of Minnesota
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
Eligibility
- Min Age
- 21 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1995-02-28
- Completion
- 2001-12-31
Countries
- United States
Study Locations
More Related Trials
-
Medicinal Nicotine for Preventing Cue Induced Craving
NCT02347605 ·Status: COMPLETED ·Phase: NA
-
Palatability of Experimental Cigarettes - Study 2
NCT01568905 ·Status: COMPLETED ·Phase: NA
-
Manipulating Tobacco Constituents in Female Menthol Smokers
NCT02048852 ·Status: COMPLETED ·Phase: NA
-
Tobacco Cessation in Postmenopausal Women (Part II) - 2
NCT00061074 ·Status: COMPLETED ·Phase: PHASE1
-
The Effects of Menthol as Delivered by an Electronic Cigarette on the Desirability of Nicotine in Tobacco Users
NCT02102100 ·Status: COMPLETED ·Phase: NA
-
Metabolism of Deuterated NNN in Smokeless Tobacco Users
NCT02414477 ·Status: TERMINATED ·Phase: PHASE1
-
Nicotine Pharmacokinetics From Research Electronic Nicotine Delivery System S-TA-U001 in Smokers and E-Cigarette Users
NCT02792426 ·Status: COMPLETED ·Phase: PHASE1
-
The Role of Nicotine and Non-Nicotine Alkaloids in E-Cigarette Use and Dependence
NCT02590393 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Nicotinic Hepatic Metabolism on Neuroreceptor Substrates of Nicotine Addiction
NCT03442413 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Early Effects of a New Oral Nicotine Replacement Product and NiQuitin™ Lozenge
NCT01075659 ·Status: COMPLETED ·Phase: PHASE2
-
Nicotine Delivery Rate and Its Abuse Potential: Impact of Menthol
NCT03580525 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effects of Menthol in E-cigarettes on Smoking Behaviors
NCT04521647 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of High Dose Transdermal Nicotine for Fast Metabolizers of Nicotine
NCT00956943 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Chantix on Relapse Prevention for Smoking Cessation
NCT00948649 ·Status: COMPLETED ·Phase: PHASE4
-
Smoking Cessation in Menthol Flavored Cigarette Smokers
NCT02342327 ·Status: COMPLETED ·Phase: NA
-
Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy - 1
NCT00067158 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Bupropion Versus Bupropion + Naltrexone for Smoking Cessation
NCT00419731 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Metabolism-informed Care for Smoking Cessation
NCT03227679 ·Status: COMPLETED ·Phase: NA
-
CSD170304: Study to Assess Nicotine Uptake in Smokers From Electronic and Combustible Cigarettes
NCT03294356 ·Status: COMPLETED ·Phase: NA
-
N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers
NCT00967005 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Oral Tobacco Products Compared to a Medicinal Nicotine
NCT00710034 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Pharmacotherapy for Smoking Cessation Among Methadone Patients
NCT00060814 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Flavors on Nicotine Reinforcement in Smokers
NCT03243630 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Human Laboratory Study Of Varenicline in Smokers
NCT00709696 ·Status: COMPLETED ·Phase: NA
-
Effect of Nicotine on Brain Reward Pathways
NCT02346539 ·Status: COMPLETED ·Phase: PHASE1